I-Hsun Li
Overview
Explore the profile of I-Hsun Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang T, Li S, Fann L, Li I, Liu T, Hung H, et al.
J Cent Nerv Syst Dis
. 2025 Jan;
17():11795735241312661.
PMID: 39790641
Background: Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Previous research has confirmed that isofraxidin can reduce macrophage expression and inhibit peripheral inflammation. However, its effects on...
2.
Li I, Liu T, Chen Y, Hsiao S, Hung H, Fann L, et al.
Biomed Pharmacother
. 2023 May;
164:114880.
PMID: 37224751
3,4-methylenedioxymethamphetamine (MDMA) is a popular recreational drug, however over 200 studies demonstrate that acute (e.g. hyperthermia, rhabdomyolysis) and chronic (e.g. neurotoxicity) toxicity effects of MDMA were observed in different animals....
3.
Zhong P, Chen Y, Li I, Wen Y, Kao H, Chiang K, et al.
Eur Arch Otorhinolaryngol
. 2022 Jul;
280(2):695-702.
PMID: 35790554
Background: It is plausible that immunopathological processes associated with psoriasis might contribute to the occurrence of olfactory or taste dysfunction. However, the actual association was still unknown. Purpose: To determine...
4.
Kao H, Chen H, Chiang K, To S, Li I, Huang Y, et al.
Healthcare (Basel)
. 2022 May;
10(5).
PMID: 35628047
Taste and smell dysfunction are suspected to be associated with substance use. However, representative epidemiological studies remain insufficient. This cross-sectional study explored the relationship between drug use (including cannabis or...
5.
To S, Kao L, Shih J, Li I, Huang T, Tsai C, et al.
Int J Environ Res Public Health
. 2022 May;
19(10).
PMID: 35627534
The modified dose (MD) regimen of pembrolizumab (2 mg/kg or 100 mg every 3 weeks) is an alternative option to reduce the financial burden resulting from the extremely high cost...
6.
Lin P, Li I, Yang H, Chiang K, Wang C, Kao L
Int J Environ Res Public Health
. 2021 Nov;
18(22).
PMID: 34831700
The use of illegal drugs may be a risk factor of hearing loss. However, very few studies with large sample size have investigated the relationship between illegal drug use and...
7.
Pan K, Li I, Kao H, Chen Y, Zhong P, Kao L
Front Pharmacol
. 2021 Jul;
12:596375.
PMID: 34290604
To date, it remains uncertain whether benzodiazepine receptor agonists (BZRAs) are aggravating factors even though these drugs can elevate the levels of biomarkers associated with the development of psoriasis. Therefore,...
8.
Zhong P, Li I, Shih J, Yeh C, Chiang K, Kao L
Int J Epidemiol
. 2021 Mar;
50(5):1686-1697.
PMID: 33742212
Background: Increasing numbers of animal studies have found that sudden sensorineural hearing loss (SSNHL) is related to the mechanism of serotonergic modulation. However, the relationship between antidepressants and SSNHL is...
9.
Tzeng Y, Li I, Kao H, Shih J, Yeh C, Chen Y, et al.
J Affect Disord
. 2020 Dec;
281:590-596.
PMID: 33257042
Background: Inflammation may mediate the relationship between major depressive disorder (MDD) and psoriasis. However, it is unclear whether anti-depressants can decrease the subsequent risk of psoriasis among MDD patients. This...
10.
Fan H, Chang Y, Tsai J, Chiang K, Shih J, Yeh K, et al.
Cell Transplant
. 2020 Oct;
29:963689720947416.
PMID: 33028106
While Parkinson's disease (PD) and attention-deficit hyperactivity disorder (ADHD) are two distinct conditions, it has been hypothesized that they share several overlapping anatomical and neurochemical changes. In order to investigate...